id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3329255,d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80,Q1,GOVERNMENT SOLUTIONS LLC,401103251,"OTSUKA AMERICA PHARMACEUTICAL, INC.",2025,first_quarter,DEF,"Military Health Care, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Defense authorizations and appropriations issues related to mental health and PTSD.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-06T18:03:19-04:00
3530117,d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80,Q1,GOVERNMENT SOLUTIONS LLC,401103251,"OTSUKA AMERICA PHARMACEUTICAL, INC.",2025,first_quarter,DEF,"Military Health Care, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Defense authorizations and appropriations issues related to mental health and PTSD.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-06T18:03:19-04:00
3601322,d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80,Q1,GOVERNMENT SOLUTIONS LLC,401103251,"OTSUKA AMERICA PHARMACEUTICAL, INC.",2025,first_quarter,DEF,"Military Health Care, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Defense authorizations and appropriations issues related to mental health and PTSD.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-06T18:03:19-04:00